PURPOSE OF REVIEW: To consolidate and synthesize the most recent evidence on the effects of platelet-rich plasma (PRP) in the knee with respect to osteoarthritis, meniscal injuries, ACL reconstruction, total knee arthroplasty (TKA), and high tibial osteotomy. RECENT FINDINGS: PRP has been shown to be more beneficial in the context of knee osteoarthritis compared to both placebo and hyaluronic acid. Direct comparison with corticosteroid injections has been sparsely studied. It has also been shown to improve the clinical postoperative course in meniscal injuries and to a lesser extent TKA. Radiographic improvements without clinically significant benefits have been observed with ACL reconstructions treated with PRP. PRP injections may be more beneficial than other current non-surgical management options for specific knee pathologies. Further research should broaden the knowledge of PRP effects on the knee, and identify the type of PRP, growth factor distribution, and route of administration associated with the most benefit.
PURPOSE OF REVIEW: To consolidate and synthesize the most recent evidence on the effects of platelet-rich plasma (PRP) in the knee with respect to osteoarthritis, meniscal injuries, ACL reconstruction, total knee arthroplasty (TKA), and high tibial osteotomy. RECENT FINDINGS: PRP has been shown to be more beneficial in the context of knee osteoarthritis compared to both placebo and hyaluronic acid. Direct comparison with corticosteroid injections has been sparsely studied. It has also been shown to improve the clinical postoperative course in meniscal injuries and to a lesser extent TKA. Radiographic improvements without clinically significant benefits have been observed with ACL reconstructions treated with PRP. PRP injections may be more beneficial than other current non-surgical management options for specific knee pathologies. Further research should broaden the knowledge of PRP effects on the knee, and identify the type of PRP, growth factor distribution, and route of administration associated with the most benefit.
Authors: James L Cook; Patrick A Smith; Chantelle C Bozynski; Keiichi Kuroki; Cristi R Cook; Aaron M Stoker; Ferris M Pfeiffer Journal: J Orthop Res Date: 2015-10-02 Impact factor: 3.494
Authors: Mario Orrego; Catalina Larrain; Julio Rosales; Luis Valenzuela; José Matas; Juan Durruty; Hernán Sudy; Rodrigo Mardones Journal: Arthroscopy Date: 2008-09-30 Impact factor: 4.772
Authors: A V Stone; R F Loeser; K S Vanderman; D L Long; S C Clark; C M Ferguson Journal: Osteoarthritis Cartilage Date: 2013-12-04 Impact factor: 6.576
Authors: Jorge Chahla; Mark E Cinque; Nicolas S Piuzzi; Sandeep Mannava; Andrew G Geeslin; Iain R Murray; Grant J Dornan; George F Muschler; Robert F LaPrade Journal: J Bone Joint Surg Am Date: 2017-10-18 Impact factor: 5.284
Authors: Dorottya Kardos; Bence Marschall; Melinda Simon; István Hornyák; Adél Hinsenkamp; Olga Kuten; Zsuzsanna Gyevnár; Gábor Erdélyi; Tamás Bárdos; Tamás Mirkó Paukovits; Krisztián Magos; György Béres; Kálmán Szenthe; Ferenc Bánáti; Susan Szathmary; Stefan Nehrer; Zsombor Lacza Journal: Cells Date: 2019-08-03 Impact factor: 6.600